» Articles » PMID: 27295129

Investigating Core Genetic-and-epigenetic Cell Cycle Networks for Stemness and Carcinogenic Mechanisms, and Cancer Drug Design Using Big Database Mining and Genome-wide Next-generation Sequencing Data

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2016 Jun 14
PMID 27295129
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have demonstrated that cell cycle plays a central role in development and carcinogenesis. Thus, the use of big databases and genome-wide high-throughput data to unravel the genetic and epigenetic mechanisms underlying cell cycle progression in stem cells and cancer cells is a matter of considerable interest. Real genetic-and-epigenetic cell cycle networks (GECNs) of embryonic stem cells (ESCs) and HeLa cancer cells were constructed by applying system modeling, system identification, and big database mining to genome-wide next-generation sequencing data. Real GECNs were then reduced to core GECNs of HeLa cells and ESCs by applying principal genome-wide network projection. In this study, we investigated potential carcinogenic and stemness mechanisms for systems cancer drug design by identifying common core and specific GECNs between HeLa cells and ESCs. Integrating drug database information with the specific GECNs of HeLa cells could lead to identification of multiple drugs for cervical cancer treatment with minimal side-effects on the genes in the common core. We found that dysregulation of miR-29C, miR-34A, miR-98, and miR-215; and methylation of ANKRD1, ARID5B, CDCA2, PIF1, STAMBPL1, TROAP, ZNF165, and HIST1H2AJ in HeLa cells could result in cell proliferation and anti-apoptosis through NFκB, TGF-β, and PI3K pathways. We also identified 3 drugs, methotrexate, quercetin, and mimosine, which repressed the activated cell cycle genes, ARID5B, STK17B, and CCL2, in HeLa cells with minimal side-effects.

Citing Articles

Aberrant DNA methylation as a key modulator of cell death pathways: insights into cancer progression and other diseases.

Zahoor A, Khazer R, Mehraj I, Gani U, Fayaz F, Khanday F Funct Integr Genomics. 2025; 25(1):50.

PMID: 40024973 DOI: 10.1007/s10142-025-01552-x.


MicroRNA-98: the multifaceted regulator in human cancer progression and therapy.

Hazari V, Samali S, Izadpanahi P, Mollaei H, Sadri F, Rezaei Z Cancer Cell Int. 2024; 24(1):209.

PMID: 38872210 PMC: 11177407. DOI: 10.1186/s12935-024-03386-2.


The increase in cell death rates in caloric restricted cells of the yeast helicase mutant rrm3 is Sir complex dependent.

Ivessa A, Singh S Sci Rep. 2023; 13(1):17832.

PMID: 37857740 PMC: 10587150. DOI: 10.1038/s41598-023-45125-z.


Genetic and Epigenetic Host-Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach.

Hsu B, Chen B Biomedicines. 2023; 11(6).

PMID: 37371627 PMC: 10295364. DOI: 10.3390/biomedicines11061531.


Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.

Lin Y, Chen B Int J Mol Sci. 2022; 23(18).

PMID: 36142321 PMC: 9499358. DOI: 10.3390/ijms231810409.


References
1.
Singh A, Chappell J, Trost R, Lin L, Wang T, Tang J . Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells. Stem Cell Reports. 2013; 1(6):532-44. PMC: 3871385. DOI: 10.1016/j.stemcr.2013.10.009. View

2.
Krude T . Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner. Exp Cell Res. 1999; 247(1):148-59. DOI: 10.1006/excr.1998.4342. View

3.
Okita K, Yamanaka S . Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci. 2011; 366(1575):2198-207. PMC: 3130417. DOI: 10.1098/rstb.2011.0016. View

4.
Chen J, Gu W, Yang L, Chen C, Shao R, Xu K . Nanotechnology in the management of cervical cancer. Rev Med Virol. 2015; 25 Suppl 1:72-83. DOI: 10.1002/rmv.1825. View

5.
Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S . The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol. 2010; 649(1-3):84-91. DOI: 10.1016/j.ejphar.2010.09.020. View